Diffuse Cutaneous Systemic Sclerosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-07-22
Clinical Trial Update: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 2]
A Phase 2 double-blind trial evaluating BMS-986020 versus placebo in diffuse cutaneous systemic sclerosis has been withdrawn.